Authors:
Turner, SD
Wijnhoven, SWP
Tinwell, H
Lashford, LS
Rafferty, JA
Ashby, J
Vrieling, H
Fairbairn, LJ
Citation: Sd. Turner et al., Assays to predict the genotoxicity of the chromosomal mutagen etoposide - focussing on the best assay, MUT RES-GTE, 493(1-2), 2001, pp. 139-147
Authors:
Fairbairn, LJ
Chinnasamy, N
Lashford, LS
Chinnasamy, D
Rafferty, JA
Citation: Lj. Fairbairn et al., Enhancing hemopoietic drug resistance: A rationale for reconsidering the clinical use of mitozolomide, CANC GENE T, 7(2), 2000, pp. 233-239
Authors:
Turner, SD
Rafferty, JA
Fairbairn, LJ
Ashby, J
Tinwell, H
Eckert, HG
Baum, C
Lashford, LS
Citation: Sd. Turner et al., The effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrow, LEUKEMIA, 14(10), 2000, pp. 1796-1802
Authors:
Bellantuono, I
Lashford, LS
Rafferty, JA
Fairbairn, LJ
Citation: I. Bellantuono et al., The expression of full length Gp91-Phox protein is associated with reducedamphotropic retroviral production, HAEMATOLOG, 85(5), 2000, pp. 451-457
Authors:
Thompson, MJ
Abdul-Rahman, S
Baker, TG
Rafferty, JA
Margison, GP
Bibby, MC
Citation: Mj. Thompson et al., Role of O-6-alkylguanine-DNA alkyltransferase in the resistance of mouse spermatogenic cells to O-6-alkylating agents, J REPR FERT, 119(2), 2000, pp. 339-346
Authors:
Rajaguru, P
Fairbairn, LJ
Ashby, J
Willington, MA
Turner, S
Woolford, LA
Chinnasamy, N
Rafferty, JA
Citation: P. Rajaguru et al., Genotoxicity studies on the azo dye Direct Red 2 using the in vivo mouse bone marrow micronucleus test, MUT RES-GTE, 444(1), 1999, pp. 175-180
Authors:
Longhurst, SJ
Rafferty, JA
Arrand, JR
Cortez, N
Giraud, C
Berns, KI
Fairbairn, LJ
Citation: Sj. Longhurst et al., Recombinant adeno-associated virus-mediated expression of O-6-alkylguanine-DNA-alkyltransferase protects human epithelial and hematopoietic cells against chloroethylating agent toxicity, HUM GENE TH, 10(2), 1999, pp. 301-310
Authors:
Jelinek, J
Rafferty, JA
Cmejla, R
Hildinger, M
Chinnasamy, D
Lashford, LS
Ostertag, W
Margison, GP
Dexter, TM
Fairbairn, LJ
Baum, C
Citation: J. Jelinek et al., A novel dual function retrovirus expressing multidrug resistance 1 and O-6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents, GENE THER, 6(8), 1999, pp. 1489-1493
Authors:
Chinnasamy, N
Rafferty, JA
Lashford, LS
Chinnasamy, D
Margison, GP
Thatcher, N
Dexter, TM
Fairbairn, LJ
Citation: N. Chinnasamy et al., Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells - implications for chemoprotective gene therapy, LEUKEMIA, 13(11), 1999, pp. 1776-1783
Authors:
Herring, CJ
Deans, B
Elder, RH
Rafferty, JA
MacKinnon, J
Barzilay, G
Hickson, ID
Hendry, JH
Margison, GP
Citation: Cj. Herring et al., Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines, BR J CANC, 80(7), 1999, pp. 940-945
Authors:
Bibby, MC
Thompson, MJ
Rafferty, JA
Margison, GP
McElhinney, RS
Citation: Mc. Bibby et al., Influence of O-6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-l-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice, BR J CANC, 79(9-10), 1999, pp. 1332-1339
Authors:
McElhinney, RS
Donnelly, DJ
McCormick, JE
Kelly, J
Watson, AJ
Rafferty, JA
Elder, RH
Middleton, MR
Willington, MA
McMurry, TBH
Margison, GP
Citation: Rs. Mcelhinney et al., Inactivation of O-6-alkylguanine-DNA alkyltransferase. 1. Novel O-6-(hetarylmethyl)guanines having basic rings in the side chain, J MED CHEM, 41(26), 1998, pp. 5265-5271